Yasheng Zhu

Yasheng Zhu

Harvard University - Cambridge / United States
Medical and Health Sciences / Urology
AD Scientific Index ID: 1386570
person_outline Yasheng Zhu's MOST POPULAR ARTICLES
1-) Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillanceJ Zhang, X Bu, H Wang, Y Zhu, Y Geng, NT Nihira, Y Tan, Y Ci, F Wu, ...Nature 553 (7686), 91, 20185602018
2-) Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activationP Zhang, D Wang, Y Zhao, S Ren, K Gao, Z Ye, S Wang, CW Pan, Y Zhu, ...Nature medicine 23 (9), 1055, 20171962017
3-) Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancerF Wang, S Ren, R Chen, J Lu, X Shi, Y Zhu, W Zhang, T Jing, C Zhang, ...Oncotarget 5 (22), 11091, 20141752014
4-) Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progressionS Ren, GH Wei, D Liu, L Wang, Y Hou, S Zhu, L Peng, Q Zhang, Y Cheng, ...European urology 73 (3), 322-339, 20181942018
5-) Truncated ERG oncoproteins from TMPRSS2-ERG fusions are resistant to SPOP-mediated proteasome degradationJ An, S Ren, SJ Murphy, S Dalangood, C Chang, X Pang, Y Cui, L Wang, ...Molecular cell 59 (6), 904-916, 20151612015